Stamenkovic Sasha, Slight Robert D
Bart's Health NHS Trust, The Royal London Hospital, Whitechapel, UK.
Freeman Hospital, Newcastle Upon Tyne, UK.
Ann Cardiothorac Surg. 2019 Mar;8(2):250-254. doi: 10.21037/acs.2018.11.10.
The benefits of minimally invasive thoracic surgery are well documented when compared to the use of standard thoracotomy. Much controversy exists, however, regarding the resource implications when using robot-assisted thoracic surgery (RATS), especially when compared to video-assisted thoracoscopic surgery (VATS). Much of the costs attributed to a particular approach center around the frequency and severity of the complications that may arise. Little exists in the literature to appropriately compare and contrast the complication rate following either of the minimally invasive approaches. There is a suggestion that many conventional open surgeons are more readily persuaded to adopt a minimally invasive approach through the use of the robotic platform, therefore reducing the complication-related costs of standard thoracotomy by an increase in minimally invasive resection rates. Further gains may be made in the ability to perform more complex minimally invasive procedures via a RATS approach without recourse to open conversion when compared to VATS. As opportunities and competition increase in the commercial market place, it is reasonable to assume costs will fall and further savings will be made.
与标准开胸手术相比,微创胸外科手术的益处已有充分记录。然而,在使用机器人辅助胸外科手术(RATS)时,尤其是与电视辅助胸腔镜手术(VATS)相比时,关于资源影响存在诸多争议。特定手术方式的大部分成本集中在可能出现的并发症的频率和严重程度上。文献中几乎没有内容能恰当地比较和对比这两种微创方法后的并发症发生率。有一种观点认为,许多传统的开放手术医生更容易被说服通过使用机器人平台采用微创方法,从而通过提高微创切除率来降低标准开胸手术与并发症相关的成本。与VATS相比,通过RATS方法在不进行开放转换的情况下进行更复杂的微创手术的能力可能会有进一步提升。随着商业市场机会和竞争的增加,可以合理地假设成本将会下降,并会进一步节省开支。